Q3 sales rose 7.7% (+5.2% at CER). Yoy, growth was respectively +10.4% and +7%.
03 Nov 2015
Increasing Somatuline growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Increasing Somatuline growth
Ipsen SA (IPN:WBO) | 0 0 5.0% | Mkt Cap: 10,144m
- Published:
03 Nov 2015 -
Author:
Armelle Moulin -
Pages:
2
Q3 sales rose 7.7% (+5.2% at CER). Yoy, growth was respectively +10.4% and +7%.